About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Philadelphia | 157 Studies

Clinical Trials Alzheimer's DiseasePhiladelphia

Alzheimer's Disease Clinical Trials in Philadelphia

Find 157 clinical trials for alzheimer's disease near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 157 trials

TerminatedOpen-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)The purpose of this study is to provide subjects who have completed participation in a Phase 2 or Phase 3 trial of LMTM continued access to therapy and to evaluate the long-term…NCT02245568·Phoenix, Arizona and 134 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

TerminatedProgress of Mild Alzheimer's Disease in Participants on Solanezumab Versus PlaceboTo test the idea that solanezumab will slow the cognitive decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.NCT01900665·Phoenix, Arizona and 197 others

CompletedCitalopram for Agitation in Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of citalopram for agitation in Alzheimer's dementia.NCT00898807·Los Angeles, California and 7 others

Active not recruitingA Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.NCT04437511·Gilbert, Arizona and 273 others

TerminatedStudy of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of 2 fixed doses of EVP-6124 compared to placebo for 26 weeks in subjects with mild to moderate Alzheimer's…NCT01969123·Phoenix, Arizona and 81 others

Active not recruitingNeuroinflammation Imaging in ADThis research study is being done to learn more about inflammation in the brain using Positron Emission Tomography/Computed Tomography (PET/CT) imaging in people with Alzheimer's…NCT04274998·Philadelphia, Pennsylvania

Terminated221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseThe primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical…NCT02484547·Birmingham, Alabama and 179 others

CompletedBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)This is a multicenter, double-blind, placebo controlled, randomized, outpatient multiple dose study in male and female patients ages 50 to less than 89 years with mild to moderate…NCT00574132·Birmingham, Alabama and 250 others

CompletedEffects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44The core study assessed the efficacy of a higher dose of rivastigmine 13.3 mg/24 h transdermally (15 cm\^2 patch) compared to a lower dose of the rivastigmine 4.6 mg/24 h…NCT00948766·Tempe, Arizona and 94 others

CompletedUsability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease RehabilitationThe focus of this work is to explore the use of modern mobile technology to enable people with Alzheimer's disease to improve their abilities to perform activities of daily living…NCT02005380·Amman, Amman Governorate

CompletedA Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)The primary specific aim of this clinical trial is to determine whether treatment with rofecoxib or naproxen for one year will slow the rate of decline of cognitive function in…NCT00004845·Phoenix, Arizona and 39 others

CompletedMemory Impairment Study (Mild Cognitive Impairment Study)The National Institute on Aging (NIA) is launching a nationwide treatment study targeting individuals with mild cognitive impairment (MCI), a condition characterized by a memory…NCT00000173·Phoenix, Arizona and 71 others

CompletedEnhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their CaregiversAim 1.NCT00294307·Philadelphia, Pennsylvania and 2 others

CompletedLong-term Safety of Tafamidis in Subjects With Transthyretin CardiomyopathyOpen label study to evaluate tafamidis for the treatment of transthyretin cardiomyopathyNCT02791230·Birmingham, Alabama and 79 others

CompletedGenes, Exercise, Memory and NeurodegenerationThe primary purpose of this pilot study is to determine whether African Americans with mild Alzheimer's disease (AD) can be enrolled and retained in a 6-month aerobic…NCT01021644·Washington D.C., District of Columbia and 1 other

Active not recruitingA Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's DiseaseThis is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to…NCT05531656·Birmingham, Alabama and 49 others

CompletedProject TAP: Tailored Activities ProjectSpecific Aims 1. Establish a preliminary effect size for the impact of the intervention on depressive affect and agitated behaviors in persons with dementia in 4 months 2.NCT00259467·Philadelphia, Pennsylvania

TerminatedA 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's DiseaseThe name of this trial is MissionAD1.NCT02956486·Chandler, Arizona and 257 others

Active not recruitingA Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)The purpose of this study is to learn about health care use, costs, and clinical outcomes over time for amyloid positive participants with early stages of AD in the United States.NCT02951598·Anaheim, California and 76 others

CompletedA Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan InterpretationThis study will evaluate the performance of physician readers trained to read flortaucipir-PET (positron emission tomography) scans.NCT03901092·Philadelphia, Pennsylvania

Page 1 of 8Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia